Cryptotanshinone Reverses Cisplatin Resistance of Human Lung Carcinoma A549 Cells through Down-Regulating Nrf2 Pathway

Publisher： Karger

E-ISSN： 1421-9778|37|2|816-824

ISSN： 1015-8987

Source： Cellular Physiology and Biochemistry, Vol.37, Iss.2, 2015-09, pp. : 816-824

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil

By  

Cellular Physiology and Biochemistry, Vol. 35, Iss. 6, 2015-04 ,pp. : 2333-2348

Karger

Access to resources Recommend Favorite

The Role of Nrf2 and Cytoprotection in Regulating Chemotherapy Resistance of Human Leukemia Cells

By Rushworth Stuart A.   MacEwan David J.  

Cancers, Vol. 3, Iss. 2, 2011-03 ,pp. : 1605-1621

MDPI

Access to resources Recommend Favorite

NBM-T-BMX-OS01, an Osthole Derivative, Sensitizes Human Lung Cancer A549 Cells to Cisplatin through AMPK-Dependent Inhibition of ERK and Akt Pathway

By  

Cellular Physiology and Biochemistry, Vol. 36, Iss. 3, 2015-06 ,pp. : 893-906

Karger

Access to resources Recommend Favorite

Periostin Contributes to Cisplatin Resistance in Human Non-Small Cell Lung Cancer A549 Cells via Activation of Stat3 and Akt and Upregulation of Survivin

By  

Cellular Physiology and Biochemistry, Vol. 38, Iss. 3, 2016-03 ,pp. : 1199-1208

Karger

Access to resources Recommend Favorite

Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA

By  

Cellular Physiology and Biochemistry, Vol. 35, Iss. 6, 2015-04 ,pp. : 2255-2271

Karger

Access to resources Recommend Favorite